Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiroyuki Fukuda

Showing results (151-160 of 157) with videos related to

Pageof 16
Sort By:
You have reached the last page of results.This site can display upto 157 results.
Abdominal Imaging|June 4, 2013
High-intensity focused ultrasound ablation assisted using color Doppler imaging for the treatment of hepatocellular carcinomasHiroyuki Fukuda, Kazushi Numata, Akito Nozaki, et al.
Proteomics|April 30, 2008
Phosphorylation of measles virus nucleoprotein upregulates the transcriptional activity of minigenomic RNAKyoji Hagiwara, Hiroki Sato, Yoshihisa Inoue, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|September 30, 2020
Intraprocedurally EOB-MRI/US fusion imaging focusing on hepatobiliary phase findings can help to reduce the recurrence of hepatocellular carcinoma after radiofrequency ablationFeiqian Wang, Kazushi Numata, Hiromi Nihonmatsu, et al.
Abdominal Radiology (New York)|January 3, 2021
The value of hepatobiliary phase in EOB-MRI in predicting hypervascularization outcome of non-hypervascular hypointense lesions in high-risk patients for hepatocellular carcinomaFeiqian Wang, Kazushi Numata, Makoto Chuma, et al.
Journal of Digestive Diseases|December 16, 2014
Hepatic arterial infusion chemotherapy with cisplatin and sorafenib in hepatocellular carcinoma patients unresponsive to transarterial chemoembolization: a propensity score-based weightingMasaaki Kondo, Manabu Morimoto, Tomohiro Ishii, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|March 29, 2019
Circulating microRNA-1246 as a possible biomarker for early tumor recurrence of hepatocellular carcinomaMakoto Chuma, Hidenori Toyoda, Juntaro Matsuzaki, et al.
Cancers|January 30, 2020
Early Changes in Circulating FGF19 and Ang-2 Levels as Possible Predictive Biomarkers of Clinical Response to Lenvatinib Therapy in Hepatocellular CarcinomaMakoto Chuma, Haruki Uojima, Kazushi Numata, et al.
Pageof 16

Showing results (151-160 of 157) with videos related to

Sort By:
Pageof 16
You have reached the last page of results.This site can display upto 157 results.
Abdominal Imaging|June 4, 2013
High-intensity focused ultrasound ablation assisted using color Doppler imaging for the treatment of hepatocellular carcinomasHiroyuki Fukuda, Kazushi Numata, Akito Nozaki, et al.
Proteomics|April 30, 2008
Phosphorylation of measles virus nucleoprotein upregulates the transcriptional activity of minigenomic RNAKyoji Hagiwara, Hiroki Sato, Yoshihisa Inoue, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|September 30, 2020
Intraprocedurally EOB-MRI/US fusion imaging focusing on hepatobiliary phase findings can help to reduce the recurrence of hepatocellular carcinoma after radiofrequency ablationFeiqian Wang, Kazushi Numata, Hiromi Nihonmatsu, et al.
Abdominal Radiology (New York)|January 3, 2021
The value of hepatobiliary phase in EOB-MRI in predicting hypervascularization outcome of non-hypervascular hypointense lesions in high-risk patients for hepatocellular carcinomaFeiqian Wang, Kazushi Numata, Makoto Chuma, et al.
Journal of Digestive Diseases|December 16, 2014
Hepatic arterial infusion chemotherapy with cisplatin and sorafenib in hepatocellular carcinoma patients unresponsive to transarterial chemoembolization: a propensity score-based weightingMasaaki Kondo, Manabu Morimoto, Tomohiro Ishii, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|March 29, 2019
Circulating microRNA-1246 as a possible biomarker for early tumor recurrence of hepatocellular carcinomaMakoto Chuma, Hidenori Toyoda, Juntaro Matsuzaki, et al.
Cancers|January 30, 2020
Early Changes in Circulating FGF19 and Ang-2 Levels as Possible Predictive Biomarkers of Clinical Response to Lenvatinib Therapy in Hepatocellular CarcinomaMakoto Chuma, Haruki Uojima, Kazushi Numata, et al.
Pageof 16